Earth Science Tech, Inc. (OTC: ETST) announced that shareholders at its first Annual Meeting of Stockholders, held virtually on Aug. 31, 2026, approved key proposals that could pave the way for the company to uplist to a national securities exchange and overhaul its corporate governance structure.
The company revealed that stockholders authorized the board to pursue a reverse stock split, which would remain valid for 12 months. The split would be implemented only if the board deems it necessary to meet the minimum bid-price requirements for an uplisting. This move signals the company’s intention to potentially move from the OTC market to a more prestigious exchange, such as the NASDAQ or NYSE, which could enhance liquidity and visibility among institutional investors.
In a separate vote, shareholders authorized the board’s independent Special Committee to negotiate the retirement of the Series B Preferred Stock. According to the company, this action would eliminate its dual-class, super-voting control structure. By retiring this preferred stock, Earth Science Tech aims to adopt a more conventional one-share-one-vote structure, which is often viewed favorably by governance-focused investors and index funds.
The annual meeting also saw shareholders approve a cash-only “Say-on-Pay” executive compensation structure, with a three-year review cycle. Additionally, all seven director nominees were re-elected, and Semple, Marchal & Cooper, LLP was ratified as the independent registered public accounting firm.
The company noted that an audio replay of the meeting, including management guidance and a shareholder question-and-answer session, is available. For more details, the full press release can be accessed at https://ibn.fm/KCU5p.
Earth Science Tech operates as a diversified holding company in the health and wellness sector, focusing on building a vertically integrated healthcare platform. This includes compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company’s healthcare operations are supported by investments in real estate and asset management, as well as a consumer products business. The integration of patient care from consultation to fulfillment is central to its value proposition, achieved through specialized subsidiaries.
The approval of these measures comes at a critical time for the company, as it seeks to strengthen its market position and attract a broader investor base. The potential uplisting could provide access to greater capital markets, while the governance changes may improve transparency and accountability. Investors will be watching closely to see if the board exercises the reverse stock split authority and how the retirement of the Series B Preferred Stock unfolds.
For ongoing updates and news regarding ETST, interested parties can visit the company’s newsroom at https://ibn.fm/ETST.
